Bli Banque De Luxembourg Investments Gilead Sciences, Inc. Transaction History
Bli Banque De Luxembourg Investments
- $3.43 Trillion
- Q3 2025
A detailed history of Bli Banque De Luxembourg Investments transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bli Banque De Luxembourg Investments holds 10,531 shares of GILD stock, worth $1.31 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,531
Previous 20,031
47.43%
Holding current value
$1.31 Million
Previous $2.22 Billion
46.44%
% of portfolio
0.03%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,371Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...